- Country: Lithuania
- Summary: Medicines Compensated from the Fund of Rare Diseases (No. 10839) - Ak
- LTT Ref No: 118694345
- Deadline: 18 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 702912
- Notice Type: Tender
- Document Ref. No.: 289173-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Medicines compensated from the Rare Disease Fund (see more in the procurement documents)
1. Atalurene
2. Atalurene
3. Levocarnitine
4. Parental Nutrition Amino Acid, Electrolyte and Fat Acid Mixture
DOC Title: Medicines, compensated from the Fund of Rare Diseases (No. 10839) -AK
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines Compensated from the Fund of Rare Diseases (No. 10839) - Ak - Lithuania Tender
The PUBLIC INSTITUTION VILNIUS UNIVERSITY HOSPITAL SANTARA CLINIC (PV), a Government sector organization in Lithuania, has announced a new tender for Medicines Compensated from the Fund of Rare Diseases (No. 10839) - Ak. This tender is published on LithuaniaTenders under LTT Ref No: 118694345 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-18.
The estimated tender value is EUR 702912, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
